ATE291740T1 - Verfahren für die bestimmung von plättchen aktivierendem faktor - Google Patents
Verfahren für die bestimmung von plättchen aktivierendem faktorInfo
- Publication number
- ATE291740T1 ATE291740T1 AT02730840T AT02730840T ATE291740T1 AT E291740 T1 ATE291740 T1 AT E291740T1 AT 02730840 T AT02730840 T AT 02730840T AT 02730840 T AT02730840 T AT 02730840T AT E291740 T1 ATE291740 T1 AT E291740T1
- Authority
- AT
- Austria
- Prior art keywords
- paf
- plale
- determination
- mass spectrometry
- highly sensitive
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 230000004913 activation Effects 0.000 title 1
- HVAUUPRFYPCOCA-AREMUKBSSA-N 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCOC[C@@H](OC(C)=O)COP([O-])(=O)OCC[N+](C)(C)C HVAUUPRFYPCOCA-AREMUKBSSA-N 0.000 abstract 7
- 108010003541 Platelet Activating Factor Proteins 0.000 abstract 7
- 239000012472 biological sample Substances 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 238000003556 assay Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000011156 evaluation Methods 0.000 abstract 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 abstract 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001164982 | 2001-05-31 | ||
| PCT/JP2002/005369 WO2002097435A2 (en) | 2001-05-31 | 2002-05-31 | Assay method for platelet-activating factor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE291740T1 true ATE291740T1 (de) | 2005-04-15 |
Family
ID=19007715
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02730840T ATE291740T1 (de) | 2001-05-31 | 2002-05-31 | Verfahren für die bestimmung von plättchen aktivierendem faktor |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20040175776A1 (de) |
| EP (1) | EP1390759B1 (de) |
| JP (1) | JP4087334B2 (de) |
| AT (1) | ATE291740T1 (de) |
| AU (1) | AU2002302977A1 (de) |
| BR (1) | BR0205443A (de) |
| DE (1) | DE60203388T2 (de) |
| ES (1) | ES2239230T3 (de) |
| NO (1) | NO20030461D0 (de) |
| WO (1) | WO2002097435A2 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG182971A1 (en) * | 2007-07-26 | 2012-08-30 | Phenomenome Discoveries Inc | Methods for the diagnosis, risk assessment, and monitoring of autism spectrum disorders |
| JP5351076B2 (ja) * | 2010-02-26 | 2013-11-27 | 杏林製薬株式会社 | オンライン固相抽出による生体試料液中薬剤成分の定量方法 |
| JP5982676B2 (ja) * | 2011-02-28 | 2016-08-31 | 学校法人 いわき明星大学 | 抗paf活性を有するビオチニル化ペプチド化合物 |
| WO2016140981A1 (en) * | 2015-03-02 | 2016-09-09 | Colonaryconcepts Llc | Compounds and methods for peg metabolite and peg breakdown product assays |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR78246B (de) * | 1981-01-23 | 1984-09-26 | Ciba Geigy Ag | |
| DE3445950A1 (de) * | 1984-12-17 | 1986-06-19 | A. Nattermann & Cie GmbH, 5000 Köln | Verfahren zur isolierung von lysophosphatidylcholin-freiem phosphatidylcholin aus ei-pulver |
| FR2630006B1 (fr) * | 1988-04-18 | 1991-07-19 | Pasteur Institut | Nouvelle preparation de recepteurs du paf et nouvelle methode de dosage du paf |
-
2002
- 2002-05-31 JP JP2003500563A patent/JP4087334B2/ja not_active Expired - Fee Related
- 2002-05-31 EP EP02730840A patent/EP1390759B1/de not_active Expired - Lifetime
- 2002-05-31 AT AT02730840T patent/ATE291740T1/de not_active IP Right Cessation
- 2002-05-31 ES ES02730840T patent/ES2239230T3/es not_active Expired - Lifetime
- 2002-05-31 US US10/478,644 patent/US20040175776A1/en not_active Abandoned
- 2002-05-31 BR BR0205443-4A patent/BR0205443A/pt not_active Application Discontinuation
- 2002-05-31 DE DE60203388T patent/DE60203388T2/de not_active Expired - Fee Related
- 2002-05-31 AU AU2002302977A patent/AU2002302977A1/en not_active Abandoned
- 2002-05-31 WO PCT/JP2002/005369 patent/WO2002097435A2/en not_active Ceased
-
2003
- 2003-01-29 NO NO20030461A patent/NO20030461D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE60203388D1 (de) | 2005-04-28 |
| JP2004527770A (ja) | 2004-09-09 |
| JP4087334B2 (ja) | 2008-05-21 |
| BR0205443A (pt) | 2003-07-08 |
| WO2002097435A2 (en) | 2002-12-05 |
| DE60203388T2 (de) | 2006-04-13 |
| WO2002097435A3 (en) | 2003-09-04 |
| NO20030461D0 (no) | 2003-01-29 |
| EP1390759B1 (de) | 2005-03-23 |
| US20040175776A1 (en) | 2004-09-09 |
| EP1390759A2 (de) | 2004-02-25 |
| ES2239230T3 (es) | 2005-09-16 |
| AU2002302977A1 (en) | 2002-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60239968D1 (de) | Sche | |
| DE60023539D1 (de) | Immunologischer nachweis von rna:dna hybriden auf mikroarrays | |
| MXPA02010106A (es) | Determinacion de suficiencia de volumen de muestra en dispositivos biosensores. | |
| DE60231974D1 (de) | Inline-testeinrichtung und verfahren zur verwendung | |
| MX340856B (es) | Sistema y metodos que determinan concentracion de analito utilizando amperometria resuelta en tiempo. | |
| ATE295541T1 (de) | Verfahren und vorrichtung zur untersuchung von wirksstoffskandidaten und zur bestimmung ihrer pharmakokinetischen parametern | |
| CY1111229T1 (el) | Μεθοδος προσδιορισμου ρευματοειδους αρθριτιδας με μετρηση αντι-ccp και ιντερλευκλινης 6 | |
| DE59813993D1 (de) | Analytisches messgerät mit stechhilfe | |
| CA2322858A1 (en) | Detection of analytes by fluorescent lanthanide chelates | |
| ATE393914T1 (de) | Nachweis von biomolekülen unter verwendung poröser biosensoren und raman-spektroskopie | |
| DK1311707T3 (da) | Massespektroskopisk analyse af biopolymerer | |
| WO2005080602A3 (en) | Immunological detection of rna:dna hybrids on microarrays | |
| BRPI0610092A2 (pt) | mÉtodos para a detecÇço de um analito e de um Ácido nucleico em uma amostra, e para sintetizaÇço de uma molÉcula de Ácido nucleico ou de anÁlago de Ácido nucleico, kit reagente, usos do mesmo, de um composto, e de um mÉtodo, molÉcula de Ácido nucleico ou de anÁlogo de Ácido nucleico, produto de metalizaÇço, produto associado, e, composto | |
| DE602006011756D1 (de) | Komplexformierungs- und -trennungsverfahren | |
| ATE370414T1 (de) | Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs | |
| DE602005014386D1 (de) | Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome | |
| WO2004042403A3 (en) | Methods, device and instrument for detection of analytes | |
| ATE291740T1 (de) | Verfahren für die bestimmung von plättchen aktivierendem faktor | |
| ATE391912T1 (de) | Direkte bestimmung des quotients von analyt- zu referenzmolekülen | |
| WO2002099381A3 (en) | A single-cell biosensor for the measurement of gpcr ligands in a test sample | |
| DE60220288D1 (de) | Bestimmung der Genauigkeit eines Probevolumens in Biosensoren | |
| ATE534037T1 (de) | Verwendung des proteins asc als marker für brustkrebs | |
| CA2586654A1 (en) | Use of asc as a marker for colorectal cancer | |
| DE602004031571D1 (de) | Enzymhemmungsimmunverfahren | |
| DE602004001994D1 (de) | Verwendung des proteins masp als marker für kolorektale karzinome |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |